Phase 1b Safety and Efficacy Study of TRU-016
Clinical trial NCT01644253 · TERMINATED
Trial details
- NCT number
- NCT01644253
- Sponsor
- Aptevo Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2020-02-24
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.